Home » Topics » Regulatory

Regulatory
RSS

Approvable letter issued for Lexapro in GAD

Oct. 1, 2003

Integrin antagonists useful for angiogenesis-related ocular diseases

Sep. 30, 2003

Thyrogen indication extended in Europe

Sep. 30, 2003

FDA advisory committee recommends expanded label for Provigil

Sep. 30, 2003

Lumiracoxib approved by the MHRA for osteoarthritis and other indications

Sep. 25, 2003

New formulation of Singulair available for young children with asthma

Sep. 25, 2003

Six-month priority review granted for Eloxatin sNDA

Sep. 22, 2003

Eisai submits E.U. Pariet application for on-demand therapy of symptomatic GERD

Sep. 22, 2003

FDA approves expanded Synagis labeling for children with congenital heart disease

Sep. 19, 2003

Cerezyme approved for type 3 Gaucher's disease in E.U.

Sep. 19, 2003